SECURITIES PURCHASE AGREEMENT dated as of June 2, 2006, by and among INNOFONE.COM, INCORPORATED, COGENT CAPITAL INVESTMENTS LLC and COGENT CAPITAL FINANCIAL LLC
EXHIBIT
10.1
dated
as
of June 2, 2006,
by
and
among
XXXXXXXX.XXX,
INCORPORATED,
COGENT
CAPITAL INVESTMENTS LLC
and
COGENT
CAPITAL FINANCIAL LLC
Table
of Contents
Page
SECTION
1.
|
PURCHASE
AND SALE OF SECURITIES
|
1
|
SECTION
2.
|
THE
CLOSING
|
1
|
2.1.
|
The
Closing
|
1
|
2.2.
|
Conditions
to Closing
|
2
|
SECTION
3.
|
REPRESENTATIONS,
WARRANTIES AND COVENANTS OF THE COMPANY
|
3
|
SECTION
4.
|
REPRESENTATIONS,
WARRANTIES AND COVENANTS OF THE PURCHASER
|
14
|
4.1.
|
Organization
|
14
|
4.2.
|
Authorization,
Enforcement, and Validity
|
14
|
4.3.
|
Consents
and Approvals; No Violation
|
14
|
4.4.
|
Investment
Experience
|
15
|
4.5.
|
Investment
Intent And Limitation On Dispositions
|
15
|
4.6.
|
Information
And Risk
|
15
|
4.7.
|
Restricted
Securities
|
16
|
4.8.
|
Legends
|
16
|
4.9.
|
Brokers
or Finders
|
16
|
4.10.
|
Confidential
Treatment
|
17
|
SECTION
5.
|
SURVIVAL
OF REPRESENTATIONS AND WARRANTIES
|
17
|
SECTION
6.
|
INDEMNIFICATION
|
17
|
SECTION
7.
|
NOTICES
|
20
|
SECTION
8.
|
MISCELLANEOUS.
|
20
|
8.1.
|
Amendments
|
21
|
8.2.
|
Headings
|
21
|
8.3.
|
Severability
|
21
|
8.4.
|
Governing
Law And Forum
|
21
|
8.5.
|
Counterparts
|
21
|
i
8.6.
|
Entire
Agreement
|
21
|
8.7.
|
Expenses
|
21
|
Appendix
A
|
Certificate
of Designations for Preferred Stock
|
Appendix
B
|
Company
Counsel Opinion
|
Appendix
C
|
Disclosure
Schedules
|
ii
SECURTIES
PURCHASE AGREEMENT
THIS
SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made as of the 2nd day of
June 2006 by and among Xxxxxxxx.xxx, Incorporated (the “Company”), a Nevada
corporation, with its principal offices at 0000 Xxxxx Xxxxxx, Xxxxx 0000 Xxxxx
Xxxxxx, XX 00000, and Cogent Capital Investments LLC, a Delaware limited
liability company (the “Purchaser”) and Cogent Capital Financial LLC, a Delaware
limited liability company (“CCF”).
IN
CONSIDERATION of the mutual covenants contained in this Agreement, and other
good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Company and the Purchaser hereby agree as follows:
Section
1.
|
Purchase
and Sale of Securities
|
1.1. Subject
to the terms and conditions of this Agreement and the Escrow Agreement (as
defined below), on the Closing Date (as defined herein), the Purchaser agrees
to
purchase and the Company agrees to issue and sell to the Purchaser
(i) 1,850,000 shares (the “Common Shares”) of the Company’s common stock,
$0. 001 par value (the “Common Stock”) and (ii) 4,815,000 shares (the
“Preferred Shares”) of the Company’s series A convertible preferred stock, $0.
01 par value (the “Preferred Stock”), at an aggregate purchase price for such
Common Shares and Preferred Shares of $50,000,000 in the form of the Bonds
delivered pursuant to Section 1(a) of the Escrow Agreement (as defined below);
and Cogent Capital Financial LLC (“CCF”) shall receive from the Company, as part
of the Initial Exchange Amount under the Equity Swap Confirmation (as defined
below), (x) 5,000,000 shares of Common Stock (the “Exchange Shares”) and (ii)
a warrant to purchase 5,000,000 shares of Common Stock (the “Warrant”) (the
Common Shares, Preferred Shares and Exchange Shares are collectively called
the
“Shares”, and the Shares and the Warrant are collectively called the
“Securities”).
1.2.
The
“Transaction Documents” consist of (a) this Agreement, (b) that certain escrow
agreement, dated as of June 2, 2006, by and among the Company, the Purchaser,
Cogent Capital Financial LLC (“CCF”) and Investors
Bank & Trust Company, a Massachusetts trust company (“Escrow Agent”), (c)
the ISDA Master Agreement, dated as of June 2, 2006, by and between the Company
and CCF (the “Master Agreement”), including the Schedule thereto, (d) the Equity
Swap Confirmation, dated June 2, 2006, by and between the Company and CCF (the
“Equity Swap Confirmation”), (e) the Credit Support Annex (including Paragraph
13 thereof) to the Master Agreement, dated June 2, 2006, between the Company
and
CCF (the “Credit Support Annex”), (f) the registration rights agreement, dated
as of June 2, 2006, by and among the Company, the Purchaser and CCF, (g) the
certificate evidencing the Warrant and (h) the certificate of designations
for
the Preferred Stock (the “Certificate of Designations”).
Section
2.
|
The
Closing
|
2.1. The
Closing.
a)
The
purchase and sale of the Securities upon the terms and conditions hereof will
take place at a closing (the “Closing”) to be held at the offices of Xxxxxxxx
& Xxxxxxxx LLP, 0000 Xxxxxx xx xxx Xxxxxxxx, Xxx Xxxx, XX 00000, or such
other location as the parties may agree, on the date hereof at the time as
shall
be agreed upon by the Company and the Purchaser (the “Closing Date”).
(b) The
Company shall provide wire transfer instructions for the payment of the Purchase
Price prior to the Closing.
(c) At
the
Closing, the Company and the Purchaser shall satisfy all of the conditions
set
forth in Sections 2.2(a) and (b), respectively.
2.2. Conditions
to Closing
(a) The
Company's obligation to complete the purchase and sale of the Securities and
deliver the stock certificates and warrants certificates to the Purchaser is
subject to:
(i) Delivery
by the Purchaser of the Purchase Price in the form of Bonds to the Escrow Agent
in the manner contemplated by Section 1(a) of the Escrow Agreement;
(ii) Delivery
by the Purchaser of copies of the following agreements duly executed by the
Purchaser: (1) this Agreement and (2) the Escrow Agreement;
(iii) Delivery
by CCF of copies of the following agreements duly executed by CCF: (1) the
Escrow Agreement, (2) the Master Agreement (including the Schedule thereto);
(3)
the Equity Swap Confirmation; (4) the Credit Support Annex to the ISDA Master
Agreement; and (5) the Registration Rights Agreement; and
(iv) the
accuracy in all material respects of the representations and warranties made
by
the Purchaser in Section 4 below as of the Closing Date and the fulfillment
in
all material respects of those undertakings of the Purchaser in this Agreement
to be fulfilled on or prior to the Closing Date.
2
(b) The
Purchaser's obligation to complete the purchase and sale of the Securities
is
subject to:
(i) Delivery
by the Company of each of the items referred to in Section 1(b) of the Escrow
Agreement in the manner contemplated thereby, with all certificates evidencing
any Securities included therein having been duly executed by the
Company;
(ii) Delivery
by the Company of the following agreements duly executed by the Company: (1)
this Agreement, (2) the Escrow Agreement, (3) the Master Agreement (including
the Schedule thereto); (4) the Credit Support Annex to the ISDA Master Agreement
and (5) the Registration Rights Agreement;
(iii) Delivery
by the Company of confirmation that the Certificate of Designations in the
form
of Appendix A hereto has been duly filed with the Secretary of State of the
State of Delaware;
(iv) the
filing of UCC-1 financing statements with respect to the Collateral Account
established under the Escrow Agreement and the items credited
thereto;
(v) the
accuracy in all material respects of the representations and warranties made
by
the Company in Section 3 below as of the Closing Date and the fulfillment in
all
material respects of those undertakings of the Company in this Agreement to
be
fulfilled on or prior to the Closing Date; and
(vi) delivery
by the Company to the Purchaser of an opinion, dated as of the Closing Date,
from Xxxxxxx Savage, LLP, counsel to the Company, in the form attached as
Appendix B hereto.
Section
3. Representations,
Warranties and Covenants of the Company.
Except as set forth on the corresponding sections of the Company's disclosure
schedule attached hereto as Appendix C, or as specifically contemplated
by this
Agreement, the Company hereby represents and warrants to, and covenants
with,
the Purchaser and CCF as of the Closing Date (or the other date specified
below)
as follows:
3.1
The
entirety of the Transaction Documents do not as of the date hereof, and will
not
as of the Closing Date, contain any untrue statement of a material fact or
omit
to state any material fact required to be stated therein or necessary in order
to make the statements therein, in light of the circumstances in which they
were
made, not misleading.
3
3.2
(a)
The Transaction Documents referenced in Section 1.2 above, at the time they
became effective or were filed with the Securities and Exchange Commission
(the
“Commission”), as the case may be, complied in all material respects with the
requirements of the Securities Act of 1933, as amended (the “Securities Act”) or
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as
applicable, and the rules and regulations of the Commission hereunder (the
“Rules”), and none of the documents as of such time contained an untrue
statement of a material fact or omitted to state a material fact required to
be
stated therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading, and
any
further documents so filed and referenced in the Transaction Documents, when
the
documents become effective or are filed with the Commission, as the case may
be,
will conform in all material respects to the requirements of the Securities
Act
or the Exchange Act, as applicable, and the Rules and as of such time will
not
contain an untrue statement of a material fact or omit to state a material
fact
required to be stated therein or necessary to make the statements therein,
in
light of the circumstances under which they are made, not
misleading.
(b)
In
the past 9 calendar months, the Company has filed all documents required to
be
filed by it prior to the date hereof with the Commission pursuant to the
reporting requirements of the Exchange Act.
3.3
The
financial statements of the Company (including all notes and schedules thereto)
included or incorporated by reference in the Company’s filings under the
Exchange Act (the “Exchange Act Filings”) present fairly the financial position
of the Company and its consolidated subsidiaries at the dates indicated and
the
statement of operations, stockholders' equity and cash flows of the Company
and
its consolidated subsidiaries for the periods specified; and the financial
statements and related schedules and notes thereto, and the unaudited financial
information included or incorporated by reference in the Exchange Act Filings
have been prepared in conformity with generally accepted accounting principles,
consistently applied throughout the periods involved.
The summary and selected financial data included in the Exchange Act Filings
present fairly the information shown therein as at the respective dates and
for
the respective periods specified and have been presented on a basis consistent
with the consolidated financial statements set forth in the Exchange Act Filings
and other financial information.
3.4
DeJoya Xxxxxxxx & Company, LLC (the “Auditor”) whose reports are filed with
the Commission as a part of the information included or incorporated by
reference in the Exchange Act Filings, are and, during the periods covered
by
their reports, were independent public accountants as required by the Securities
Act and the Rules.
4
3.5
The
Company and each of its subsidiaries, including each entity (corporation,
partnership, joint venture, association or other business organization)
controlled directly or indirectly by the Company, is duly organized, validly
existing and in good standing under the laws of their respective jurisdictions
of incorporation or organization. The Company and each of its subsidiaries
is
duly qualified to do business and is in good standing as a foreign corporation
in each jurisdiction in which the nature of the business conducted by it or
location of the assets or properties owned, leased or licensed by it requires
the qualification, except for the jurisdictions where the failure to so qualify
individually or in the aggregate would not have a material adverse effect on
the
assets, properties, condition, financial or otherwise, or in the results of
operations, business affairs or business prospects of the Company and its
subsidiaries considered as a whole (a "Material Adverse Effect"); and to the
Company's knowledge, no proceeding has been instituted in any jurisdiction
revoking, limiting or curtailing, or seeking to revoke, limit or curtail, the
power and authority or qualification.
3.6
The
Company and each of its subsidiaries has all requisite corporate power and
authority, and all necessary authorizations, approvals, consents, orders,
licenses, certificates and permits of and from all governmental or regulatory
bodies or any other person or entity (collectively, the "Permits"), to own,
lease and license its assets and properties and conduct its business, all of
which are valid and in full force and effect, except where the lack of the
Permits, individually or in the aggregate, would not have a Material Adverse
Effect. The Company and each of its subsidiaries has fulfilled and performed
in
all material respects all of its material obligations with respect to the
Permits and no event has occurred that allows, or after notice or lapse of
time
would allow, revocation or termination thereof or results in any other material
impairment of the rights of the Company hereunder. Except as may be required
under the Securities Act and state and foreign Blue Sky laws, no other Permits
are required to enter into, deliver and perform this Agreement and to issue
and
sell the Securities.
3.7
The
Company and each of its subsidiaries owns or possesses legally enforceable
rights to use all patents, patent rights, inventions, trademarks, trademark
applications, trade names, service marks, copyrights, copyright applications,
licenses, know-how and other similar rights and proprietary knowledge, if any,
and only as disclosed in its filings with the Commission (collectively,
"Intangibles") necessary for the conduct of its business. Neither the Company
nor any of its subsidiaries has received any notice of, or is not aware of,
any
infringement of or conflict with asserted rights of others with respect to
any
Intangibles.
5
3.8
The
Company and each of its subsidiaries has good and marketable title to all
personal property owned by it, in each case free and clear of all liens,
encumbrances, claims, security interests and defects, except as do not
materially affect the value of the property and do not materially interfere
with
the use made or proposed to be made of the property by the Company and its
subsidiaries. All property held under lease by the Company and its subsidiaries
is held by them under valid, existing and enforceable leases, free and clear
of
all liens, encumbrances, claims, security interests and defects, except those
that are not material and do not materially interfere with the use made or
proposed to be made of the property by the Company and its subsidiaries. Since
the date of the most recent financial statements of the Company as filed with
the Commission (i) there has not been any change in the capital stock or
long-term debt of the Company or any of its subsidiaries, or any dividend or
distribution of any kind declared, set aside for payment, paid or made by the
Company on any class of capital stock, or any material adverse change, or any
development involving a prospective material adverse change, in or affecting
the
business, properties, management, financial position, stockholders’ equity,
results of operations or prospects of the Company and its subsidiaries taken
as
a whole other than those issuances of stock to certain contractors and Company
employees in aggregate of no greater than a total 1,000,000 shares of restricted
common shares; and (ii) neither the Company nor any of its subsidiaries has
sustained any material loss or interference with its business from fire,
explosion, flood or other calamity, whether or not covered by insurance, or
from
any labor disturbance or dispute or any action, order or decree of any court
or
arbitrator or governmental or regulatory authority. Since the date of the latest
quarterly report filed by the Company with the Commission and other than those
agreements made as disclosed under the Company’s recent 8-K filings with the
Commission regarding its certain acquisitions of Mobile Technology Group, LLC
and InfoWeapons, Inc., neither the Company nor its subsidiaries has (A) issued
or agreed to issue any securities or incurred any liability or obligation,
direct or contingent, for borrowed money, except the liabilities or obligations
incurred in the ordinary course of business or (B) entered into any transaction
not in the ordinary course of business.
3.9 Neither
the Company nor any of its subsidiaries is in violation of any term or provision
of its charter or by-laws or of any franchise, license, permit, judgment,
decree, order, statute, rule or regulation, where the consequences of the
violation, individually or in the aggregate, would have a Material Adverse
Effect. Neither the Company nor any of its subsidiaries, if a subsidiary is
a
party, nor to the Company's knowledge, any other party is in default in the
observance or performance of any term or obligation to be performed by it under
any the agreement, and no event has occurred which with notice or lapse of
time
or both would constitute the a default, in any such case which default or event,
individually or in the aggregate, would have a Material Adverse Effect.
6
3.10
Each
of this Agreement and the other Transaction Documents has been duly authorized,
executed and delivered by the Company and constitutes the legal, valid and
binding obligation of the Company, enforceable in accordance with its
terms.
3.11
Neither the execution, delivery and performance of this Agreement or the other
Transaction Documents by the Company nor the consummation of any of the
transactions contemplated hereby or thereby (including, without limitation,
the
issuance and sale by the Company of the Securities) will give rise to a right
to
terminate or accelerate the due date of any payment due under, or conflict
with
or result in the breach of any term or provision of, or constitute a default
(or
an event which with notice or lapse of time or both would constitute a default)
under, or require any consent or waiver under, or result in the execution or
imposition of any lien, charge or encumbrance upon any properties or assets
of
the Company or its subsidiaries pursuant to the terms of, any indenture,
mortgage, deed of trust or other agreement or instrument to which the Company
or
any of its subsidiaries is a party or by which either the Company or its
subsidiaries or any of their properties or businesses is bound, or any
franchise, license, permit, judgment, decree, order, statute, rule or regulation
applicable to the Company or any of its subsidiaries or violate any provision
of
the charter or by-laws of the Company or any of its subsidiaries, except for
the
consents or waivers which have already been obtained and are in full force
and
effect.
3.12
Other than accounting for those issuance in the normal course of business since
the Company’s last quarterly report filing with the Commission and other than
the adjustments to certain warrants issued to N.I.R. Group as disclosed in
the
Company’s Form 8-K filings on or about June 2, 2006, the Company has authorized
and outstanding capital stock as set forth in its recent quarterly report filed
with the Commission. The certificates evidencing the Securities are in due
and
proper legal form and have been duly authorized for issuance by the Company.
All
of the issued and outstanding shares of Common Stock and preferred stock have
been duly and validly issued and are fully paid and nonassessable. There are
no
statutory preemptive or other similar rights to subscribe for or to purchase
or
acquire any shares of Common Stock of the Company or any of its subsidiaries
or
any such rights pursuant to its Articles of Incorporation or by-laws or any
agreement or instrument to or by which the Company or any of its subsidiaries
is
a party or bound. The Securities, when sold pursuant to this Agreement, will
be
duly and validly issued, fully paid and nonassessable, will be issued free
and
clear of any security interests, liens, encumbrances, equities or claims. and
none of them will be issued in violation of any preemptive or other similar
right. The Company has reserved from its duly authorized capital stock the
maximum number of shares of Common Stock issuable pursuant to the Warrants
(the
“Warrant Shares”). The Warrant Shares, when issued and delivered upon exercise
of the Warrants in accordance with their terms, will be duly authorized, validly
issued, fully paid and nonassessable and will be issued free and clear of any
security interests, liens, encumbrances, equities or claims. All outstanding
shares of capital stock of each of the Company's subsidiaries have been duly
authorized and validly issued, and are fully paid and nonassessable and are
owned directly by the Company or by another wholly-owned subsidiary of the
Company free and clear of any security interests, liens, encumbrances, equities
or claims.
7
3.13
Other than (a) that certain Registration Agreement entered between the Company
and N.I.R. Group for the piggyback registration of shares underlying the warrant
to purchase 750,000 shares of Company common stock at a period no sooner than
180 days subsequent to May 25, 2006 and (b) other than that certain piggyback
registration right relating to 750,000 common stock shares validly issued to
Xxxxxx X. Xxxxxx under his Employment Agreement with the Company; and (c) other
than those certain piggyback registration rights granted under that certain
Binding Term Sheet entered by and between the Company and the owners of Mobile
Technology Group, LLC in connection with the Company’s acquisition of Mobile
Technology Group, LLC, no holder of any security of the Company has any right,
which has not been waived, to have any security owned by the holder included
in
any registration statement contemplated by the Transaction Documents (each,
a
“Registration Statement”) or to demand registration of any security owned by the
holder for a period of 180 days after the date of this Agreement.
3.14
There are no legal or governmental proceedings pending to which the Company
or
any of its subsidiaries is a party or of which any property of the Company
or
any of its subsidiaries is the subject which, if determined adversely to the
Company or any of its subsidiaries could individually or in the aggregate have
a
Material Adverse Effect; and to the knowledge of the Company, no the proceedings
are threatened or contemplated by governmental authorities or threatened by
others.
3.15
All
necessary corporate action has been duly and validly taken by the Company and
to
authorize the execution, delivery and performance of this Agreement and the
issuance and sale of the Securities by the Company.
3.16
Neither the Company nor any of its subsidiaries is involved in any labor dispute
nor, to the knowledge of the Company, is any the dispute threatened, which
dispute would have a Material Adverse Effect. The Company is not aware of any
existing or imminent labor disturbance by the employees of any of its principal
suppliers or contractors which would have a Material Adverse Effect. The Company
is not aware of any threatened or pending litigation between the Company or
its
subsidiaries and any of its executive officers which, if adversely determined,
could have a Material Adverse Effect and has no reason to believe that the
officers will not remain in the employment of the Company.
8
3.17
The
Company has not taken, nor will it take, directly or indirectly, any action
designed to or which might reasonably be expected to cause or result in, or
which has constituted or which might reasonably be expected to constitute,
the
stabilization or manipulation of the price of the Common Stock or any security
of the Company to facilitate the sale or resale of any of the
Securities.
3.18
The
Company and each of its subsidiaries has filed all Federal, state, local and
foreign tax returns which are required to be filed through the date hereof,
which returns are true and correct in all material respects or has received
timely extensions thereof, and has paid all taxes shown on the returns and
all
assessments received by it to the extent that the same are material and have
become due. There are no tax audits or investigations pending, which if
adversely determined would have a Material Adverse Effect; nor are there any
material proposed additional tax assessments against the Company or any of
its
subsidiaries.
3.19
The
Company has taken no action designed to, or likely to have the effect of,
terminating the registration of the Common Stock under the OTC Bulletin
Board.
3.20
The
books, records and accounts of the Company and its subsidiaries accurately
and
fairly reflect, in reasonable detail, the transactions in, and dispositions
of,
the assets of, and the results of operations of, the Company and its
subsidiaries. The Company and each of its subsidiaries maintains a system of
internal accounting controls sufficient to provide reasonable assurances that
(i) transactions are executed in accordance with management's general or
specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted
accounting principles and to maintain asset accountability, (iii) access to
assets is permitted only in accordance with management's general or specific
authorization and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken
with
respect to any differences.
3.21
The
Company has established and maintains disclosure controls and procedures (as
the
term is defined in Rule 13a-15 under the Exchange Act), which: (i) are designed
to ensure that material information relating to the Company is made known to
the
Company’s principal executive officer and its principal financial officer by
others within the Company, particularly during the periods in which the periodic
reports required under the Exchange Act are required to be prepared; (ii)
provide for the periodic evaluation of the effectiveness of the disclosure
controls and procedures at the end of the periods in which the periodic reports
are required to be prepared; and (iii) are effective in all material respects
to
perform the functions for which they were established.
9
3.22
Based on the evaluation of its disclosure controls and procedures, the Company
is not aware of (i) any significant deficiency in the design or operation of
internal controls which could adversely affect the Company’s ability to record,
process, summarize and report financial data or any material weaknesses in
internal controls; or (ii) any fraud, whether or not material, that involves
management or other employees who have a role in the Company’s internal
controls.
3.23
The
Auditor has not been engaged by the Company to perform any “prohibited
activities” (as defined in Section 10A of the Exchange Act).
3.24
There are no material off-balance sheet arrangements (as defined in Item 303
of
Regulation S-B) that have or are reasonably likely to have a material current
or
future effect on the Company’s financial condition, revenues or expenses,
changes in financial condition, results of operations, liquidity, capital
expenditures or capital resources.
3.25
The
Company and its subsidiaries are insured by insurers of recognized financial
responsibility against the losses and risks and in the amounts as are customary
in the businesses in which they are engaged or propose to engage after giving
effect to the transactions described in the Company’s filings with the
Commission for the past 9 months; all policies of insurance and fidelity or
surety bonds insuring the Company or any of its subsidiaries or the Company's
or
its subsidiaries' respective businesses, assets, employees, officers and
directors are in full force and effect; the Company and each of its subsidiaries
are in compliance with the terms of the policies and instruments in all material
respects; and neither the Company nor any subsidiary of the Company has any
reason to believe that it will not be able to renew its existing insurance
coverage as and when the coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business at a cost that
is
not materially greater than the current cost. Neither the Company nor any of
its
subsidiaries has been denied any insurance coverage which it has sought or
for
which it has applied.
3.26
Each
approval, consent, order, authorization, designation, declaration or filing
of,
by or with any regulatory, administrative or other governmental body necessary
in connection with the execution and delivery by the Company of this Agreement
and the consummation of the transactions herein contemplated required to be
obtained or performed by the Company.
3.27
The
Company is not and, after giving effect to the offering and sale of the
Securities and the application of proceeds thereof, will not be an "investment
company" within the meaning of the Investment Company Act of 1940, as amended
(the "Investment Company Act").
10
3.28
The
Company or any other person associated with or acting on behalf of the Company
including, without limitation, any director, officer, agent or employee of
the
Company or its subsidiaries, has not, directly or indirectly, while acting
on
behalf of the Company or its subsidiaries (i) used any corporate funds for
unlawful contributions, gifts, entertainment or other unlawful expenses relating
to political activity; (ii) made any unlawful payment to foreign or
domestic government officials or employees or to foreign or domestic political
parties or campaigns from corporate funds; (iii) violated any provision of
the
Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any other
unlawful payment.
3.29
The
operations of the Company and its subsidiaries are and have been conducted
at
all times in compliance with applicable financial recordkeeping and reporting
requirements of the Currency and Foreign Transactions Reporting Act of 1970,
as
amended, the money laundering statutes of all jurisdictions, the rules and
regulations hereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any governmental agency
(collectively, the “Money Laundering Laws”) and no action, suit or proceeding by
or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of it subsidiaries with respect to the Money
Laundering Laws is pending, or to the best knowledge of the Company,
threatened.
3.30
Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company
or
any of its subsidiaries is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Treasury Department
(“OFAC”); and the Company will not directly or indirectly use the proceeds of
the offering, or lend, contribute or otherwise make available the proceeds
to
any subsidiary, joint venture partner or other person or entity, for the purpose
of financing the activities of any person currently subject to any U.S.
sanctions administered by OFAC.
3.31
The
Company has fulfilled its obligations, if any, under the minimum funding
standards of Section 302 of the U.S. Employee Retirement Income Security Act
of
1974 ("ERISA") and the regulations and published interpretations hereunder
with
respect to each "plan" as defined in Section 3(3) of ERISA and the regulations
and published interpretations in which its employees are eligible to participate
and each such plan is in compliance in all material respects with the presently
applicable provisions of ERISA and the regulations and published
interpretations. No "Reportable Event" (as defined in 12 ERISA) has occurred
with respect to any "Pension Plan" (as defined in ERISA) for which the Company
could have any liability.
11
3.32
Each
of
the Company, its directors and officers has not distributed and will not
distribute prior to the Closing Date, any offering material in connection with
the offering and sale of the Securities other than the Transaction
Documents.
3.33No
broker, investment banker, financial advisor or other individual, corporation,
general or limited partnership, limited liability company, firm, joint venture,
association, enterprise, joint securities company, trust, unincorporated
organization or other entity (each a “Person”), other than the Placement Agent,
the fees and expenses of which will be paid by the Company, is entitled to
any
broker's, finder's, financial advisor's or other similar fee or commission
in
connection with the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of the Company.
3.34The
Company intends to use the net proceeds from the sale of the Securities for
working capital purposes.
3.35
Neither the Company nor any Person acting on its behalf, (i) has engaged in
any
form of general solicitation or general advertising (within the meaning of
Regulation D under the Securities Act) in connection with the offer or sale
of
the Securities, (ii) has, directly or indirectly, made any offer or sale of
any
security or solicited any offer to buy any security, under any circumstances
that would require registration of the Securities under the Securities Act
or
(iii) has issued any shares of Common Stock or shares of any series of preferred
stock or other securities or instruments convertible into, exchangeable for
or
otherwise entitling the holder thereof to acquire shares of Common Stock which
would be integrated with the sale of the Securities to the Purchaser for
purposes of the Securities Act or of any applicable stockholder approval
provisions, including, without limitation, under the rules and regulations
of
the Nasdaq National Market, nor will the Company or any of its subsidiaries
or
affiliates take any action or steps that would require registration of any
of
the Securities under the Securities Act or cause the offering of the Securities
to be integrated with other offerings. Assuming the accuracy of the
representations and warranties of Purchasers contained herein, the offer and
sale of the Securities by the Company to the Purchasers pursuant to the Stock
Purchase Agreements will be exempt from the registration requirements of the
Securities Act.
12
3.36
The
subsidiaries of the Company are not currently prohibited, directly or
indirectly, under any agreement or other instrument to which any such subsidiary
is a party or is subject, from paying any dividends to the Company, from making
any other distribution on the subsidiary’s capital stock, from repaying to the
Company any loans or advances to the subsidiary from the Company or from
transferring any of the subsidiary’s properties or assets to the
Company.
3.37
No
person has the right, which right has not been waived, to require the Company
or
its subsidiaries to register any securities for sale under the Securities Act
by
reason of the filing of the Registration Statement with the Commission or the
issuance and sale of the Securities.
3.38
The
Company shall file with the SEC a current report on Form 8-K under the Exchange
Act describing the transactions contemplated hereby and attaching as exhibits
thereto all material documents relating to the transactions contemplated
hereby.
Section
4.
|
Representations,
Warranties And Covenants Of the
Purchaser.
|
Each
of
the Purchaser and CCF hereby represents and warrants to, and covenants with,
the
Company as of the Closing Date (or the other date specified below) as
follows:
4.1. Organization.
Each of the Purchaser and CCF is an entity duly organized and validly existing
in good standing (to the extent such concepts are applicable) under the laws
of
its jurisdiction of organization. Each of the Purchaser and CCF has all
requisite corporate power and authority and all necessary governmental approvals
to carry on its business as now being conducted, except as would not result
in a
Material Adverse Effect on the Purchaser's or CCF’s ability to consummate the
transactions contemplated by this Agreement.
4.2. Authorization,
Enforcement, and Validity.
Each of the Purchaser and CCF has the requisite power and authority to enter
into this Agreement and to consummate the transactions contemplated hereby.
Each
of the Purchaser and CCF has taken all necessary action to authorize the
execution, delivery and performance of this Agreement. Upon the execution and
delivery of this Agreement, this Agreement shall constitute a valid and binding
obligation of the Purchaser and CCF enforceable in accordance with its terms,
except as enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors' and contracting
parties' rights generally and except as enforceability may be subject to general
principles of equity.
13
4.3. Consents
and Approvals; No Violation.
The execution, delivery and performance of this Agreement by the Purchaser
and
CCF and the consummation by the Purchaser and CCF of the transactions
contemplated hereby will not (i) result in a violation of the Purchaser's and
CCF’s organizational documents; (ii) conflict with, or constitute a default or
give to others any rights of termination, amendment, acceleration or
cancellation of, any material agreement, indenture or instrument to which the
Purchaser or CCF is a party (except for the conflicts, defaults, terminations,
amendments, accelerations, cancellations and violations as would not,
individually or in the aggregate, result in a Material Adverse Effect on the
Purchaser's or CCF’s ability to consummate the transactions contemplated by this
Agreement); or (iii) result in a violation of any law, rule, regulation, order,
judgment or decree applicable to the Purchaser or CCF or any of their its
Subsidiaries, except for the violations as would not, individually or in the
aggregate, result in a Material Adverse Effect on the Purchaser's ability to
consummate the transactions contemplated by this Agreement. Each of the
Purchaser and CCF is not required to obtain any consent, authorization or order
of, or make any filing or registration with, any court or governmental agency
or
any regulatory or self-regulatory agency in order for it to execute, deliver
or
perform any of its obligations under or contemplated by this Agreement, except
where the failure to obtain such consents, authorization or orders or to make
such filings or registrations would not, individually or in the aggregate,
result in a Material Adverse Effect on the Purchaser's or CCF’s ability to
consummate the transactions contemplated by this Agreement.
4.4. Investment
Experience.
Each of the Purchaser and CCF is an accredited investor within the meaning
of
Rule 501 of Regulation D promulgated under the Securities Act, is knowledgeable,
sophisticated and experienced in making, and is qualified to make, decisions
with respect to investments in shares representing an investment decision like
that involved in the purchase of the Securities.
4.5. Investment
Intent And Limitation On Dispositions.
Each of the Purchaser and CCF is acquiring Securities for its own
account for investment only and has no intention of selling or distributing
any
of the Securities or any arrangement or understanding with any other Persons
regarding the sale or distribution of the Securities except in accordance with
the provisions of Section 4.7 and except as would not result in a violation
of
the Securities Act. The Purchaser and CCF will not, directly or indirectly,
offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers
to
buy, purchase or otherwise acquire or take a pledge of) any of the Securities
except in accordance with the provisions of Section 4.7 or pursuant to and
in
accordance with the Securities Act.
4.6. Information
And Risk.
Each of
the Purchaser and CCF acknowledges that each of the Purchaser and CCF is a
sophisticated investor, has such knowledge and experience in financial and
business matters in general and has full familiarity with the current business
and future business prospects of the Company and the financial and other affairs
of the Company and acknowledges that it has had access to and has received
sufficient information about the Company, including any and all such information
requested by the Purchaser and CCF in order to make an informed decision as
to
the sale of the Securities to the Purchaser and CCF and the transactions
contemplated hereby. In addition, the Purchaser and CCF acknowledge that each
has had access to the officers, directors and employees of the Company to
discuss the business, affairs and prospects of the Company and has had the
opportunity to obtain additional information necessary to evaluate the merits
and the risks of engaging in the transactions contemplated by this
Agreement.
14
4.7. Restricted
Securities. Each of the Purchaser and CCF understands and
acknowledges that the sale of the Shares has not been registered under the
Act,
or the securities laws of any state or any analogous securities laws of any
applicable foreign jurisdiction (collectively, "Applicable Laws") and have
been
issued in reliance upon an exemption from the Act for non-public or limited
offerings. Each of the Purchaser and CCF understands that the Shares are
"restricted securities" and must be held indefinitely unless the sale or other
transfer thereof is subsequently registered pursuant to any Applicable Laws
or
an exemption from such registration is available at that time, and each of
the
Purchaser and CCF agrees to comply with all Applicable Laws in connection with
listing or qualification of the Shares thereunder.
4.8. Legends.
Certificates for the Securities shall contain a restrictive legend substantially
in the following form:
THE
SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT”), OR ANY OTHER
APPLICABLE SECURITIES LAWS, INCLUDING THE SECURITIES LAWS OF ANY APPLICABLE
FOREIGN JURISDICTION, AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES
LAWS, IF APPLICABLE. NEITHER THESE SECURITIES NOR ANY INTEREST OR PARTICIPATION
HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED,
HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR SUCH OTHER SECURITIES LAWS
OR
PURSUANT TO A TRANSACTION THAT IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH
REGISTRATION REQUIREMENTS.
4.9. Brokers
or Finders.
No broker, investment banker, financial advisor or other Person is entitled
to
any broker's, finder's, financial advisor's or other similar fee or commission
in connection with the transactions contemplated hereby based upon arrangements
made by or on behalf of the Purchaser.
15
4.10. Confidential
Treatment. The Purchaser and CCF shall hold in strict confidence all
information concerning this Agreement and the offering of the Securities until
the earlier of the time as the Company has made a public announcement concerning
this Agreement or the offering of the Securities.
4.11. The
Purchaser and CCF or any other person associated with or acting on behalf of
the
Purchaser and CCF including, without limitation, any director, officer, agent
or
employee of the Purchaser and CCF or their subsidiaries, has not, directly
or
indirectly, while acting on behalf of the Purchaser and CCF or their
subsidiaries (i) used any corporate funds for unlawful contributions, gifts,
entertainment or other unlawful expenses relating to political activity;
(ii) made any unlawful payment to foreign or domestic government officials
or employees or to foreign or domestic political parties or campaigns from
corporate funds; (iii) violated any provision of the Foreign Corrupt Practices
Act of 1977, as amended; or (iv) made any other unlawful payment.
4.12. The
operations of the Purchaser and CCF and their subsidiaries are and have been
conducted at all times in compliance with applicable financial recordkeeping
and
reporting requirements of the Currency and Foreign Transactions Reporting Act
of
1970, as amended, the money laundering statutes of all jurisdictions, the rules
and regulations hereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any governmental agency
(collectively, the “Money Laundering Laws”) and no action, suit or proceeding by
or before any court or governmental agency, authority or body or any arbitrator
involving the Purchaser or CCF or any of it subsidiaries with respect to the
Money Laundering Laws is pending, or to the best knowledge of the Purchasers
or
CCF, threatened.
4.13. The
Purchaser and CCF and any of their subsidiaries , to the knowledge of the
Purchaser and CCF, any director, officer, agent, employee or affiliate of the
Purchasers and CCF or any of their subsidiaries is not currently subject to
any
U.S. sanctions administered by OFAC.
Section
5.
|
Survival
of Representations and
Warranties.
|
Notwithstanding
any investigation made by any party to this Agreement, all representations
and
warranties made by the Company and the Purchaser and CCF herein shall survive
for a period of one (1) year following the Closing Date.
Section
6.
|
Indemnification.
|
(a) For
purposes of this Section 6:
16
(i) the
term
“Purchaser” shall include the Purchaser and any affiliate (as the term is
defined pursuant to Rule 12b-2 promulgated under the Exchange Act) of the
Purchaser, including CCF;
(ii) the
term
“Prospectus” shall mean the prospectus and any amendment or supplement thereto
in the form first filed with the Commission pursuant to Rule 424(b) promulgated
under the Securities Act or, if no Rule 424(b) filing is required, filed as
part
of the Registration Statement at the time of effectiveness, as supplemented
or
amended from time to time; and
(iii) the
term
“Registration Statement” shall include any final prospectus, exhibit, supplement
or amendment included in or relating to the Registration Statement.
(b) The
Company agrees to indemnify and hold harmless each of the Purchaser and each
Person, if any, who controls the Purchaser within the meaning of the Securities
Act, against any losses, claims, damages, liabilities or expenses, joint or
several, to which the Purchaser or the controlling Person may become subject,
under the Securities Act, the Exchange Act, or any other federal or state
statutory law or regulation, or at common law or otherwise (including in
settlement of any litigation, if the settlement is effected with the written
consent of the Company), insofar as the losses, claims, damages, liabilities
or
expenses (or actions in respect thereof as contemplated below) arise out of
or
are based upon any untrue statement or alleged untrue statement of any material
fact contained in the Registration Statement or Prospectus, or arise out of
or
are based upon the omission or alleged omission to state therein a material
fact
required to be stated therein or necessary to make the statements therein,
in
light of the circumstances in which they were made, not misleading, or arise
out
of or are based in whole or in part on any inaccuracy in the representations
and
warranties of the Company contained in this Agreement, or any failure of the
Company to perform its obligations hereunder, and will reimburse the Purchaser
and each such controlling Person for any legal and other expenses reasonably
incurred as the expenses are reasonably incurred by the Purchaser or the
controlling Person in connection with investigating, defending, settling,
compromising or paying any such loss, claim, damage, liability, expense or
action; provided, however, that the Company will not be liable in any such
case
to the extent that any such loss, claim, damage, liability or expense arises
out
of or is based upon (i) an untrue statement or alleged untrue statement or
omission or alleged omission made in the Registration Statement or Prospectus
in
reliance upon and in conformity with written information furnished to the
Company by or on behalf of the Purchaser expressly for use therein, (ii) the
failure of the Purchaser to comply with the covenants and agreements contained
in Section 4.7 above respecting sale of the Securities, (iii) the inaccuracy
of
any representations made by the Purchaser herein or (iv) any statement or
omission in any Prospectus that is corrected in any subsequent Prospectus that
was delivered to the Purchaser a reasonable time prior to the pertinent sale
or
sales by the Purchaser, and provided that the Purchaser has been notified by
the
Company that the earlier Prospectus should no longer be delivered by the
Purchaser.
17
(c) Each
Purchaser will severally, and not jointly, indemnify and hold harmless the
Company, each of its directors, each of its officers who signed the Registration
Statement and each Person, if any, who controls the Company within the meaning
of the Securities Act, against any losses, claims, damages, liabilities or
expenses to which the Company, each of its directors, each of its officers
who
signed the Registration Statement or controlling Person may become subject,
under the Securities Act, the Exchange Act, or any other federal or state
statutory law or regulation, or at common law or otherwise (including in
settlement of any litigation, if the settlement is effected with the written
consent of the Purchaser) insofar as the losses, claims, damages, liabilities
or
expenses (or actions in respect thereof as contemplated below) arise out of
or
are based upon (i) any failure by the Purchaser to comply with the covenants
and
agreements contained in Section 4.7 above respecting the sale of the Securities,
(ii) the inaccuracy of any representation made by the Purchaser herein or (iii)
any untrue or alleged untrue statement of any material fact contained in the
Registration Statement or the Prospectus, or the omission or alleged omission
to
state therein a material fact required to be stated therein or necessary to
make
the statements therein, in light of the circumstances in which they were made,
not misleading, in each case to the extent, but only to the extent, that the
untrue statement or alleged untrue statement or omission or alleged omission
was
made in the Registration Statement or Prospectus in reliance upon and in
conformity with written information furnished to the Company by or on behalf
of
the Purchaser expressly for use therein, and will reimburse the Company, each
of
its directors, each of its officers who signed the Registration Statement or
controlling Person for any legal and other expense reasonably incurred, as
the
expenses are reasonably incurred by the Company, each of its directors, each
of
its officers who signed the Registration Statement or controlling Person in
connection with investigating, defending, settling, compromising or paying
any
the loss, claim, damage, liability, expense or action; provided, however, that
the aggregate liability of any Purchaser hereunder shall not exceed the Purchase
Price paid by the Purchaser to the Company on the Closing Date. No Purchaser
shall be liable for the indemnification obligations of any other
Purchaser.
18
(d) Promptly
after receipt by an indemnified party under this Section 6 of notice of the
threat or commencement of any action, the indemnified party will, if a claim
in
respect thereof is to be made against an indemnifying party under this Section
6, promptly notify the indemnifying party in writing thereof, but the omission
so to notify the indemnifying party will not relieve it from any liability
which
it may have to any indemnified party hereunder or otherwise to the extent it
is
not prejudiced as a result of the failure. In case any the action is brought
against any indemnified party and the indemnified party seeks or intends to
seek
indemnity from an indemnifying party, the indemnifying party will be entitled
to
participate in, and, to the extent that it may wish, jointly with all other
indemnifying parties similarly notified, to assume the defense thereof with
counsel reasonably satisfactory to the indemnified party; provided, however,
if
the defendants in any such action include both the indemnified party and the
indemnifying party and the indemnified party shall have reasonably concluded
that there may be a conflict between the positions of the indemnifying party
and
the indemnified party in conducting the defense of any such action or that
there
may be legal defenses available to it and/or other indemnified parties which
are
different from or additional to those available to the indemnifying party,
the
indemnified party or parties shall have the right to select separate counsel
to
assume the legal defenses and to otherwise participate in the defense of the
action on behalf of the indemnified party or parties. Upon receipt of notice
from the indemnifying party to the indemnified party of its election to assume
the defense of the action and approval by the indemnified party of counsel,
the
indemnifying party will not be liable to the indemnified party under this
Section 6 for any legal or other expenses subsequently incurred by the
indemnified party in connection with the defense thereof unless (i) the
indemnified party shall have employed the counsel in connection with the
assumption of legal defenses in accordance with the proviso to the preceding
sentence (it being understood, however, that the indemnifying party shall not
be
liable for the expenses of more than one separate counsel, reasonably
satisfactory to the indemnifying party, representing the indemnified parties
who
are parties to the action) or (ii) the indemnified party shall not have employed
counsel reasonably satisfactory to the indemnified party to represent the
indemnified party within a reasonable time after notice of commencement of
action, in each of which cases the reasonable fees and expenses of counsel
shall
be at the expense of the indemnifying party.
Section
7.
|
Notices.
|
(a) All
notices, requests, consents and other communications hereunder shall be in
writing, shall be mailed by first-class registered or certified airmail,
confirmed facsimile or nationally recognized overnight express courier postage
prepaid, and shall be as addressed as follows:
if to the Company, to: | ||
Xxxx
Xxxxxxxx
|
||
CEO
|
||
Xxxxxxxx.xxx,
Incorporated
|
||
0000
Xxxxx Xxxxxx, Xxxxx 0000
|
||
Xxxxx
Xxxxxx, XX 00000
|
||
Telephone
No.: (000) 000-0000
|
||
Telecopy
No.: (000) 000-0000
|
||
19
with a copy to: | ||
Xxxxxxx
Savage LLP
|
||
000
Xxxxxxxxx Xxxxxx
|
||
0xx
Xxxxx
|
||
Xxx
Xxxx, Xxx Xxxx, 00000
|
||
Attention:
Xxxxxx Xxxxxx
|
||
Telephone
No.: (000) 000-0000
|
||
Telecopy
No.: (000) 000-0000
|
and
if to
the Purchaser or CCF, at its address as set forth in Escrow Agreement, or at
the
other address or addresses as may have been previously furnished to the Company
in writing in accordance with this Section 7.
(b) The
notices or other communications shall be deemed delivered upon receipt, in
the
case of overnight delivery, personal delivery, facsimile transmission (as
evidenced by the confirmation thereof), or mail.
Section
8.
|
Miscellaneous.
|
8.1. Amendments.
Any
term of this Agreement may be amended and the observance of any term of this
Agreement may be waived (either generally or in a particular instance and either
retroactively or prospectively) only with the written consent of the Company,
the Purchaser or CCF. Any amendment or waiver effected in accordance with this
Section 8.1 shall be binding upon each holder of any securities purchased under
this Agreement at the time outstanding (including securities into which the
securities are convertible), each future holder of all the securities, and
the
Company.
8.2. Headings.
The headings of the various sections of this Agreement are for convenience
of
reference only and shall not be deemed to be part of this Agreement.
8.3. Severability.
In the
event that any provision in this Agreement is held to be invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of
the
remaining provisions contained herein shall not in any way be affected or
impaired thereby.
20
8.4. Governing
Law And Forum.
This
Agreement shall be governed by and construed in accordance with the laws of
the
State of New York applicable to agreements made and to be fully performed
therein. The parties hereto agree to submit to the exclusive jurisdiction of
the
federal and state courts of the State of New York with respect to the
interpretation of this Agreement or for the purposes of any action arising
out
of or related to this Agreement.
8.5. Counterparts.
This
Agreement may be executed in two or more counterparts, each of which shall
constitute an original, and all of which together shall constitute one and
the
same instrument. In the event that any signature is delivered via facsimile
transmission, the signature shall create a valid and binding obligation of
the
party executing (or on whose behalf the signature is executed) the same with
the
same force and effect as if the facsimile signature page were an original
hereof.
8.6. Entire
Agreement.
This
Agreement contains the entire understanding of the parties with respect to
the
matters covered herein, supersede all prior agreements and understandings with
respect to the matters and executed by and among the Company and any of the
Purchasers, and, except as specifically set forth herein or therein, neither
the
Company nor the Purchasers make any representation, warranty, covenant or
undertaking with respect to the matters.
8.7. Expenses.
Each
party hereto shall pay all costs and expenses incurred by it in connection
with
the execution and delivery of this Agreement, and all the transactions
contemplated thereby, including fees of legal counsel.
21
IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
and delivered by their duly authorized representatives as of the day and year
first above written.
XXXXXXXX.XXX, INCORPORATED | |
By:
/s/
Xxxx Xxxxxxxx
|
|
Name: Xxxx Xxxxxxxx | |
Title: Chief
Executive Officer
|
|
COGENT
CAPITAL INVESTMENTS LLC
|
|
By:
/s/
Xxxx Xxxxxxx
|
|
Name:
Xxxx Xxxxxxx
Title:
Senior Principal
|
|
COGENT
CAPITAL FINANCIAL LLC
|
|
By:/s/
Xxxx Xxxxxxx
|
|
Name:
Xxxx Xxxxxxx
Title:
Senior Principal
|
22
APPENDIX
A
FORM
OF
CERTIFICATE OF DESIGNATIONS
APPENDIX
B
FORM
OF
COMPANY COUNSEL OPINION
APPENDIX
C
DISCLOSURE
SCHEDULES
[To
Come]